AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,704.00p
   
  • Change Today:
    -38.00p
  • 52 Week High: 12,294.00
  • 52 Week Low: 9,501.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.21m
  • Volume: 207,365
  • Market Cap: £165,934m
  • RiskGrade: 123

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change
13-Mar-24 Berenberg Bank Buy 10,458.00p - 120.00p Reiteration
12-Mar-24 Deutsche Sell 10,436.00p - - Reiteration
27-Feb-24 Deutsche Sell 10,328.00p - 9,500.00p Reiteration
20-Feb-24 JP Morgan Cazenove Overweight 10,204.00p - 12,500.00p Reiteration
19-Feb-24 Berenberg Bank Buy 10,418.00p 125.00p 120.00p Reiteration
16-Feb-24 Jefferies Hold 10,094.00p 11,000.00p 11,000.00p Reiteration
12-Feb-24 Barclays Outperform 9,501.00p 135.00p 125.00p Reiteration
12-Feb-24 UBS Sell 9,501.00p 10,700.00p 9,900.00p Reiteration
12-Feb-24 Stifel Buy 9,501.00p 125.00p 120.00p Reiteration
12-Feb-24 BMO Capital Markets Outperform 9,501.00p - - Reiteration
08-Feb-24 Shore Capital Buy 9,823.00p - - Reiteration
28-Nov-23 Citigroup Buy 9,900.00p - - Reiteration
27-Nov-23 Jefferies Buy 9,976.00p 13,000.00p 12,500.00p Reiteration
21-Nov-23 Berenberg Bank Buy 10,192.00p - 12,500.00p Reiteration
20-Nov-23 Barclays Buy 10,106.00p - 13,500.00p Reiteration
17-Nov-23 JP Morgan Cazenove Overweight 10,260.00p - - Reiteration
09-Nov-23 Shore Capital Buy 10,436.00p - - Reiteration
27-Oct-23 Berenberg Bank Buy 10,124.00p 133.00p 125.00p Reiteration
24-Oct-23 Shore Capital Buy 10,438.00p - - Reiteration
03-Oct-23 Deutsche Hold 10,908.00p - - Reiteration
02-Oct-23 Citigroup Buy 10,950.00p - - Reiteration
29-Sep-23 Shore Capital Buy 11,102.00p - - Reiteration
22-Sep-23 Berenberg Bank Buy 11,046.00p - 133.00p Reiteration
12-Sep-23 Barclays Overweight 10,684.00p - 13,500.00p Reiteration
05-Sep-23 Deutsche Hold 10,736.00p - 11,000.00p Reiteration
04-Sep-23 Berenberg Bank Buy 10,690.00p - 13,300.00p Reiteration
30-Aug-23 Shore Capital Buy 10,734.00p - - Reiteration
28-Jul-23 Shore Capital Buy 11,058.00p - - Reiteration
18-Jul-23 Citigroup Buy 10,280.00p - - Reiteration
12-Jul-23 UBS Buy 10,248.00p - - Upgrade
10-Jul-23 JP Morgan Cazenove Overweight 10,180.00p - - Reiteration
04-Jul-23 Citigroup Buy 10,580.00p - - Reiteration
03-Jul-23 Shore Capital Buy 10,374.00p - - Reiteration
22-Jun-23 Citigroup Buy 11,600.00p - - Reiteration
13-Jun-23 Deutsche Buy 11,740.00p - 13,000.00p Reiteration
07-Jun-23 Shore Capital Buy 11,754.00p - - Reiteration
06-Jun-23 Barclays Overweight 11,832.00p - 135.00p Reiteration
05-Jun-23 JP Morgan Cazenove Overweight 11,794.00p - - Reiteration
26-May-23 Shore Capital Buy 11,784.00p - - Reiteration
16-May-23 Deutsche Buy 12,070.00p - 13,000.00p Reiteration
15-May-23 Shore Capital Buy 12,000.00p - - Reiteration
05-May-23 Berenberg Bank Buy 11,922.00p 124.00p 135.00p Reiteration
03-May-23 Deutsche Buy 11,884.00p - 13,000.00p Reiteration
27-Apr-23 Shore Capital Buy 11,796.00p - - Reiteration
12-Apr-23 Barclays Overweight 11,822.00p - 1,350.00p Reiteration
11-Apr-23 Morgan Stanley Overweight 11,630.00p - - Upgrade
04-Apr-23 Deutsche Buy 11,244.00p - 13,000.00p Reiteration
14-Mar-23 Berenberg Bank Buy 10,686.00p 126.00p 124.00p Reiteration
09-Mar-23 Shore Capital Buy 10,866.00p - - Reiteration
07-Mar-23 Deutsche Buy 10,850.00p - 13,000.00p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,704.00p
Change Today -38.00p
% Change -0.35 %
52 Week High 12,294.00
52 Week Low 9,501.00
Volume 207,365
Shares Issued 1,550.21m
Market Cap £165,934m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
88.33% below the market average88.33% below the market average88.33% below the market average88.33% below the market average88.33% below the market average
92.59% below the sector average92.59% below the sector average92.59% below the sector average92.59% below the sector average92.59% below the sector average
Price Trend
12.34% above the market average12.34% above the market average12.34% above the market average12.34% above the market average12.34% above the market average
64.91% above the sector average64.91% above the sector average64.91% above the sector average64.91% above the sector average64.91% above the sector average
Income
85.1% below the market average85.1% below the market average85.1% below the market average85.1% below the market average85.1% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Growth
80.99% above the market average80.99% above the market average80.99% above the market average80.99% above the market average80.99% above the market average
94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average

What The Brokers Say

Strong Buy 7
Buy 13
Neutral 6
Sell 0
Strong Sell 2
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 22-Feb-24 10-Aug-23
Paid 25-Mar-24 11-Sep-23
Amount 197.00¢ 93.00¢

Trades for 28-Mar-2024

Time Volume / Share Price
10:59 25 @ 10,704.00p
10:59 48 @ 10,704.00p
10:59 15 @ 10,704.00p
10:59 15 @ 10,704.00p
10:59 37 @ 10,706.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page